tiprankstipranks
Trending News
More News >
Willis Towers Watson (WTW)
NASDAQ:WTW

Willis Towers Watson (WTW) AI Stock Analysis

Compare
396 Followers

Top Page

WTW

Willis Towers Watson

(NASDAQ:WTW)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
$317.00
▲(6.79% Upside)
Action:DowngradedDate:02/05/26
The score is driven primarily by improving fundamentals and strong cash generation, reinforced by upbeat 2026 guidance for organic growth, margin expansion, and shareholder returns. The main constraints are earnings volatility and higher leverage, while technicals are supportive but mixed due to a slightly negative MACD and valuation is reasonable rather than compelling.
Positive Factors
Strong free cash flow generation
WTW converted earnings to cash more effectively by 2025, generating $1.5bn FCF and improving cash conversion. Durable cash generation supports reinvestment, M&A funding, and repeatable shareholder returns (share buybacks), reducing reliance on capital markets over the medium term.
Sustained margin expansion and operating discipline
Material operating margin expansion reflects productivity initiatives (WeDo automation) and portfolio mix shifts toward higher‑margin HWC and R&B businesses. Higher structural margins increase earnings resilience and make future organic growth or acquisitions more value accretive over a multi-quarter horizon.
Tech-enabled broking and strategic M&A
Acquiring Newfront and targeting Cushion/Flowstone accelerates WTW's push into tech-enabled, middle‑market broking. These deals add distribution, analytics and automation capabilities that can deepen client stickiness and drive cross‑sell, supporting durable growth in higher-growth sectors like tech and fintech.
Negative Factors
Elevated leverage reduces balance-sheet flexibility
Debt nearly doubled as leverage increased materially, leaving less cushion for cyclical shocks or large opportunistic investments. Higher leverage raises interest burden sensitivity, constrains covenant headroom, and limits optionality for sizeable strategic moves without incremental refinancing risk over the next several quarters.
Revenue and earnings volatility
Inconsistent revenue growth and one‑year swings in profitability indicate exposure to cyclical client spending, insurance market cycles, and comparability adjustments (TRANZACT). This variability reduces predictability of earnings and complicates planning for sustained margin and cash flow trends across multiple reporting periods.
Acquisition financing and JV EPS headwinds
Incremental interest from recent financing and a modest EPS drag from the Willis Re JV create persistent near‑term earnings pressure. These structural headwinds will constrain free earnings growth and make EPS generation more sensitive to integration timing and cost‑synergy realization over the next 2–3 years.

Willis Towers Watson (WTW) vs. SPDR S&P 500 ETF (SPY)

Willis Towers Watson Business Overview & Revenue Model

Company DescriptionWillis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total rewards and talent issues. In addition, the company offers risk advice, insurance brokerage, and consulting services in the areas of property and casualty, aerospace, construction, and marine. Further, it offers investment consulting and discretionary management services to insurance and reinsurance companies; insurance consulting and technology, risk and capital management, pricing and predictive modeling, financial and regulatory reporting, financial and capital modeling, merger and acquisition, outsourcing, and business management services; wholesale insurance broking services to retail and wholesale brokers; and underwriting and capital management, capital market, and advisory and brokerage services. Additionally, the company provides primary medical and ancillary benefit exchange, and outsourcing services to active employees and retirees in the group and individual markets, as well as delivers healthcare and reimbursement accounts, including health savings accounts, health reimbursement arrangements, flexible spending accounts, and other consumer-directed accounts. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.
How the Company Makes MoneyWTW generates revenue primarily through three key segments: Risk and Insurance Services, Human Capital and Benefits, and Investment, Risk and Reinsurance. The Risk and Insurance Services segment earns revenue by providing insurance brokerage services, risk management consulting, and insurance program design, often charging clients a percentage of the premiums they place. In the Human Capital and Benefits segment, WTW earns fees for consulting services related to talent management, employee benefits, and health and wellness programs. The Investment, Risk and Reinsurance segment derives income from advisory services related to investment strategy and risk management, as well as reinsurance brokerage services. Additionally, WTW benefits from strategic partnerships with various financial institutions and technology providers, which enhance its service offerings and expand its market reach, further contributing to its revenue growth.

Willis Towers Watson Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where the company is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsWillis Towers Watson's revenue shows a steady recovery in North America and International markets, with notable growth in Europe since 2022. The latest earnings call highlights a 5% organic growth and a strong performance in Risk & Broking, despite insurance pricing headwinds. Strategic investments in technology and talent are expected to sustain growth, although global trade concerns and inflation pose challenges. The company's focus on innovation and strategic execution is likely to maintain momentum, but caution in consulting could temper future gains.
Data provided by:The Fly

Willis Towers Watson Earnings Call Summary

Earnings Call Date:Feb 03, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 23, 2026
Earnings Call Sentiment Positive
Earnings call highlights robust organic growth, meaningful margin expansion, strong free cash flow and active portfolio optimization (notably Newfront, Cushion, Flowstone), and continued returns to shareholders. Strengths include R&B specialization wins, HWC momentum (particularly health and career), significant AUM growth for LifeSite, and productivity gains from WeDo automation. Primary challenges are a softer ICT/consulting environment, Medicare-related near-term headwinds for BD&O, incremental interest expense from acquisition financing, and a modest EPS drag from the Willis Re JV and integration costs. Overall the positives — recurring organic growth, margin expansion, cash generation, strategic acquisitions, and clear guidance — materially outweigh the manageable near-term headwinds.
Q4-2025 Updates
Positive Updates
Strong Organic Revenue Growth
Company delivered 6% organic growth in Q4 and 5% organic growth for full year 2025, in line with mid-single-digit targets.
Margin Expansion and EPS Improvement
Adjusted operating margin expanded 80 basis points in Q4 and 130 basis points for the full year to 25.2%; adjusted diluted EPS was $8.12 in Q4 and $17.08 for the full year. Excluding TRANZACT, adjusted EPS rose ~13% year-over-year.
Health, Wealth & Career (HWC) Performance
HWC delivered 6% organic growth in Q4 and 4% for the full year; HWC operating margin was 44.3% in Q4 (up 240 bps year-over-year, or +30 bps excluding TRANZACT). Health expected to deliver high single-digit growth in 2026.
Risk & Broking (R&B) Momentum
R&B generated 7% organic growth in Q4 and 6% for the full year (7% excl. book/interest); Corporate Risk & Broking (CRB) grew 8% in the quarter and CRB North America grew high single-digits; R&B operating margin improved to 34.7% in Q4 (+120 bps).
Data Center and Specialty Wins
Won master builders risk placement with a top-10 global data center developer and supports five of the 10 largest data center developers globally; strong specialty wins in construction, surety and other lines, including two major US bank HQ renovation projects valued at well over $1 billion.
Strategic M&A and Portfolio Optimization
Closed Newfront acquisition (Jan 27), announced acquisitions of Cushion and Flowstone Partners to expand broking and wealth offerings and strengthen master trust/fintech capabilities.
LifeSite and AUM Growth
LifeSite appointed as master trust for a Fortune 50 technology company, adding £400 billion of assets under management; master trust AUM increased from $36 billion to over $46 billion in 2025 with ~$3 billion more contracted.
WeDo Automation Driving Efficiency
WeDo-enabled AI and automation cited as a major driver of operating margin expansion and ongoing productivity gains embedded across the enterprise operating model and global delivery centers.
Improved Free Cash Flow and Capital Returns
Generated $1.5 billion of free cash flow for the twelve months ended 12/31/2025 (+$279 million YoY), raising FCF margin to 15.9% (from 12.8%); returned $2 billion to shareholders in 2025 and announced at least $1 billion in repurchases planned for 2026.
Negative Updates
Insurance Consulting & Technology (ICT) Weakness
ICT revenue declined 1% in Q4 (11% growth in prior-year quarter) and full-year growth slowed to 1% from 4% last year, with client caution on large multiyear tech implementations.
BD&O Medicare Headwinds
Benefits Delivery & Outsourcing expects low single-digit growth in 2026 (vs. mid-single-digit long-term target) due to Medicare market changes and some client headcount declines; headwinds expected to be modest but persist through 2026.
TRANZACT Divestiture Impact & Adjustments
TRANZACT contributed $0.8 to adjusted EPS in 2024; results and certain margin metrics require TRANZACT adjustments for comparable year-over-year figures, creating one-time comparability effects.
Incremental Interest Expense from Acquisitions
Interest expense expected to increase due to Newfront financing, with annual interest expense projected at roughly $320 million in 2026, which will be a headwind to EPS versus 2025.
Willis Re JV and Other EPS Headwinds
Willis Re joint venture scaling is expected to be a headwind of about $0.30 to adjusted EPS in 2026; transaction and integration expenses for recent acquisitions will partially offset free cash flow margin expansion.
Consulting Demand Caution
Management continues to see caution in the consulting environment and does not expect a meaningful near-term pickup in large consulting engagements, limiting short-term ICT upside.
Company Guidance
The company guided to mid‑single‑digit organic revenue growth at the enterprise level for 2026 with continued adjusted operating margin expansion and free cash flow margin expansion (after delivering full‑year 2025 adjusted operating margin of 25.2% and Q4 margin of 36.9%), and provided segment detail: R&B (including CRB) targeted mid‑to‑high‑single‑digit organic growth (CRB mid–high single digits), HWC expects mid‑single‑digit growth overall with Health seen at high single digits, Wealth at the high end of low single digits, Career at mid‑single digits, BD&O at low single digits, and ICT at low‑to‑mid single digits; management reiterated an R&B objective of ~100 bps of operating margin expansion annually over the next two years, expects to continue expanding free cash flow above 2025’s $1.5 billion (15.9% FCF margin vs. 12.8% prior year), plans at least $1 billion of share repurchases in 2026, and disclosed key modeled items: ~ $320 million of annual interest expense (post‑Newfront financing), a ~ $0.30 EPS headwind from the Willis Re JV, an approximate $0.30 EPS foreign‑exchange tailwind (largely in Q1), and that recently announced deals (Newfront closed; Cushion and Flowstone expected in 2026) add incremental revenue (Cushion + Flowstone ~ $300 million aggregate) and will incur transaction/integration costs as synergies are captured over the next three years.

Willis Towers Watson Financial Statement Overview

Summary
Solid cash generation (free cash flow improved meaningfully and cash conversion was strong in 2025) and a sharp profitability rebound in 2025 support the score. Offsetting this, revenue growth turned slightly negative in 2025 and earnings were volatile (2024 net loss followed by 2025 rebound), while leverage has risen with debt-to-equity increasing to ~0.92, raising financial risk.
Income Statement
62
Positive
Revenue has been fairly stable over the period, but growth has been inconsistent and turned negative in 2025 (down ~1% year over year). Profitability is volatile: 2024 swung to a small net loss, followed by a strong rebound in 2025 (net margin ~16.5%). Operating profitability also improved sharply in 2025 versus 2024 (EBIT and EBITDA margins recovered meaningfully), but the large year-to-year swings reduce confidence in earnings durability.
Balance Sheet
60
Neutral
Leverage has trended higher recently, with debt-to-equity rising from ~0.41 (2021) to ~0.92 (2025), which increases financial risk and reduces balance-sheet flexibility. Equity remains sizable and return on equity recovered to ~20% in 2025 after turning negative in 2024, but the combination of rising debt load and earnings volatility is a key watch item.
Cash Flow
74
Positive
Cash generation is a relative strength: operating cash flow and free cash flow improved from 2022 through 2025, and 2025 free cash flow matched net income (strong cash conversion). Free cash flow growth was very strong in 2025 versus 2024. The main weakness is choppier multi-year growth (notably a sharp drop in 2022), indicating some variability in cash generation year to year.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.71B9.93B9.48B8.87B9.00B
Gross Profit4.08B4.43B4.14B3.80B3.75B
EBITDA2.67B823.00M2.02B2.03B3.55B
Net Income1.60B-98.00M1.05B1.01B4.22B
Balance Sheet
Total Assets29.53B27.68B29.09B31.77B34.97B
Cash, Cash Equivalents and Short-Term Investments3.13B1.89B1.42B1.26B4.69B
Total Debt6.90B5.93B5.94B5.48B5.49B
Total Liabilities21.48B19.66B19.50B21.68B21.66B
Stockholders Equity7.98B7.94B9.52B10.02B13.26B
Cash Flow
Free Cash Flow1.55B1.27B1.10B608.00M1.86B
Operating Cash Flow1.77B1.51B1.34B812.00M2.06B
Investing Cash Flow447.00M250.00M-1.08B-173.00M2.77B
Financing Cash Flow-936.00M-459.00M-1.20B-3.44B-3.11B

Willis Towers Watson Technical Analysis

Technical Analysis Sentiment
Negative
Last Price296.84
Price Trends
50DMA
319.48
Negative
100DMA
322.72
Negative
200DMA
319.71
Negative
Market Momentum
MACD
-7.72
Positive
RSI
42.96
Neutral
STOCH
57.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WTW, the sentiment is Negative. The current price of 296.84 is below the 20-day moving average (MA) of 305.37, below the 50-day MA of 319.48, and below the 200-day MA of 319.71, indicating a bearish trend. The MACD of -7.72 indicates Positive momentum. The RSI at 42.96 is Neutral, neither overbought nor oversold. The STOCH value of 57.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WTW.

Willis Towers Watson Risk Analysis

Willis Towers Watson disclosed 39 risk factors in its most recent earnings report. Willis Towers Watson reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Willis Towers Watson Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$11.97B24.2126.19%1.90%9.64%15.87%
71
Outperform
$68.42B18.7647.76%0.82%14.06%5.52%
69
Neutral
$55.53B37.606.87%1.01%17.17%19.12%
68
Neutral
$27.89B17.9120.07%1.14%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
$23.77B22.1010.98%0.77%17.87%-9.35%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WTW
Willis Towers Watson
296.84
-35.63
-10.72%
AON
Aon
324.66
-75.91
-18.95%
AJG
Arthur J Gallagher & Co
218.13
-112.15
-33.96%
BRO
Brown & Brown
70.05
-45.60
-39.43%
ERIE
Erie Indemnity Company
269.82
-128.36
-32.24%

Willis Towers Watson Corporate Events

Business Operations and StrategyM&A Transactions
Willis Towers Watson Completes Acquisition of Newfront Insurance
Positive
Jan 27, 2026

On January 27, 2026, WTW completed its previously announced acquisition of Newfront Insurance Holdings, a San Francisco-based, top-40 U.S. insurance broker known for combining specialty sector expertise with advanced AI- and automation-enabled technology. The deal brings Newfront’s Business Insurance and Total Rewards units into WTW’s Risk & Broking and Health, Wealth & Career segments, respectively, immediately expanding WTW’s U.S. middle-market footprint and strengthening its presence in high-growth sectors such as technology, fintech and life sciences; with Newfront’s leadership, including co-founder and CEO Spike Lipkin, joining WTW to drive integration, client development and technology, the transaction is set to enhance WTW’s tech-enabled broking capabilities, competitive differentiation and ability to deliver integrated, data-driven solutions to clients of all sizes.

The most recent analyst rating on (WTW) stock is a Hold with a $347.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.

Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Willis Towers Watson Secures New Term Loan Facility
Positive
Jan 9, 2026

On January 7, 2026, Willis Towers Watson and its subsidiaries Trinity Acquisition plc and Willis North America Inc. entered into a $775 million unsecured delayed draw term loan facility arranged by JPMorgan Chase Bank to support WTW’s pending acquisition of Newfront Insurance Holdings, Inc., refinance existing debt and fund general corporate purposes including working capital, capital expenditures and permitted acquisitions. The three-year facility, which can be drawn in up to four tranches following completion of the Newfront deal and is subject to customary conditions, carries interest tied to Term SOFR or a base rate with margins and commitment fees dependent on WTW’s senior unsecured credit rating, and imposes standard covenants, reporting obligations and default provisions, with WTW and certain subsidiaries providing guarantees, underscoring the company’s commitment to disciplined balance-sheet management as it advances its expansion strategy in North America.

The most recent analyst rating on (WTW) stock is a Sell with a $318.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.

Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Willis Towers Watson completes $1 billion senior notes offering
Positive
Dec 22, 2025

On December 22, 2025, Willis North America Inc., a subsidiary of Willis Towers Watson, completed a $1.0 billion public offering of senior unsecured notes, consisting of $700 million of 4.550% notes due 2031 and $300 million of 5.150% notes due 2036, fully and unconditionally guaranteed by several key Willis Towers Watson group entities in Ireland and the UK. The notes, which rank pari passu with the group’s existing senior unsecured debt and are effectively subordinated to any secured obligations, generated approximately $990 million in net proceeds that the company plans to use primarily to fund the proposed Newfront acquisition and repay $550 million of 4.400% senior notes due 2026, or, if the acquisition does not close, to fully repay the 2026 notes and redeem the 2036 notes, with any residual funds allocated to general corporate purposes.

The most recent analyst rating on (WTW) stock is a Buy with a $386.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.

M&A TransactionsPrivate Placements and Financing
Willis Towers Watson Prices $1 Billion Notes Offering
Neutral
Dec 16, 2025

On December 15, 2025, Willis North America Inc., a subsidiary of Willis Towers Watson, announced the pricing of a $1 billion offering of senior unsecured notes, with $700 million due in 2031 and $300 million due in 2036. The proceeds are intended to fund the Newfront acquisition and repay existing debt, with the offering not contingent on the acquisition’s closure.

The most recent analyst rating on (WTW) stock is a Buy with a $386.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.

Business Operations and StrategyM&A Transactions
Willis Towers Watson to Acquire Newfront Insurance
Positive
Dec 10, 2025

On December 10, 2025, Willis Towers Watson (WTW) announced a definitive agreement to acquire Newfront Insurance Holdings, Inc., a San Francisco-based broker, for $1.3 billion. This acquisition, expected to close in the first quarter of 2026, will enhance WTW’s presence in the U.S. middle market and high-growth specialties such as technology, fintech, and life sciences. The integration of Newfront’s innovative technology and AI capabilities will complement WTW’s existing investments, accelerating its technology strategy and improving operational efficiency. The transaction is anticipated to be slightly dilutive to WTW’s adjusted EPS in 2026 but accretive in 2027, with expected cost synergies of $35 million by 2028.

The most recent analyst rating on (WTW) stock is a Buy with a $362.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 05, 2026